10-Q
Quarterly Report
ACRO BIOMEDICAL CO., LTD.
CIK: 1622996
File #: 000-55643
Balance Sheet
24 line items · 2 periods
XBRL
| Item | Jun 30, 2026 | Dec 31, 2025 |
|---|---|---|
Condensed Balance Sheets | ||
ASSETS | ||
Current Assets | ||
Cash | 3,648 | 4,098 |
Other Non-Operating Current Assets | 0 | 10,000 |
Total Current Assets | 3,648 | 14,098 |
TOTAL ASSETS | 3,648 | 14,098 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
Current Liabilities | ||
Accounts Payable | 63,050 | 55,550 |
Other Current Liabilities | 0 | 20,000 |
Due to related parties | 385,387 | 325,512 |
Total Current and Total Liabilities | 448,437 | 401,062 |
Stockholders' Deficit | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 60,042 | 60,042 |
Total Stockholders' Equity | 32,319,240 | 32,311,935 |
Total Stockholders' Equity | (32,824,071) | (32,758,941) |
Total Stockholders' Deficit | (444,789) | (386,964) |
Accumulated Deficit | (32,824,071) | (32,758,941) |
Additional Paid-In Capital | 32,319,240 | 32,311,935 |
Common Stock | 60,042 | 60,042 |
Preferred Stock | 0 | 0 |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 3,648 | 14,098 |